Kyowa Kirin Co., Ltd. (4151.T)

JPY 2393.0

(0.46%)

Net Income Summary of Kyowa Kirin Co., Ltd.

  • Kyowa Kirin Co., Ltd.'s latest annual net income in 2023 was 81.18 Billion JPY , up 51.55% from previous year.
  • Kyowa Kirin Co., Ltd.'s latest quarterly net income in 2024 Q3 was 18.12 Billion JPY , down -21.69% from previous quarter.
  • Kyowa Kirin Co., Ltd. reported an annual net income of 53.57 Billion JPY in 2022, up 2.34% from previous year.
  • Kyowa Kirin Co., Ltd. reported an annual net income of 52.34 Billion JPY in 2021, up 11.31% from previous year.
  • Kyowa Kirin Co., Ltd. reported a quarterly net income of 14.63 Billion JPY for 2024 Q1, down -47.05% from previous quarter.
  • Kyowa Kirin Co., Ltd. reported a quarterly net income of 23.14 Billion JPY for 2024 Q2, up 58.17% from previous quarter.

Annual Net Income Chart of Kyowa Kirin Co., Ltd. (2023 - 1999)

Historical Annual Net Income of Kyowa Kirin Co., Ltd. (2023 - 1999)

Year Net Income Net Income Growth
2023 81.18 Billion JPY 51.55%
2022 53.57 Billion JPY 2.34%
2021 52.34 Billion JPY 11.31%
2020 47.02 Billion JPY 24.83%
2019 37.67 Billion JPY -30.76%
2018 54.41 Billion JPY 26.84%
2017 42.89 Billion JPY 129.79%
2016 18.66 Billion JPY -37.3%
2015 29.77 Billion JPY 87.28%
2014 15.89 Billion JPY -47.14%
2013 30.07 Billion JPY 24.29%
2012 24.19 Billion JPY -5.5%
2011 25.6 Billion JPY 15.37%
2010 22.19 Billion JPY 0.0%
2009 - JPY -100.0%
2008 11.72 Billion JPY -50.05%
2007 23.47 Billion JPY 84.95%
2006 12.69 Billion JPY -21.99%
2005 16.27 Billion JPY -9.25%
2004 17.93 Billion JPY 79.02%
2003 10.01 Billion JPY 18.06%
2002 8.48 Billion JPY 53.3%
2001 5.53 Billion JPY -41.09%
2000 9.39 Billion JPY -16.67%
1999 11.27 Billion JPY 0.0%

Peer Net Income Comparison of Kyowa Kirin Co., Ltd.

Name Net Income Net Income Difference
Astellas Pharma Inc. 17.04 Billion JPY -376.316%
Chugai Pharmaceutical Co., Ltd. 325.47 Billion JPY 75.055%
Ono Pharmaceutical Co., Ltd. 127.97 Billion JPY 36.56%
Santen Pharmaceutical Co., Ltd. 26.64 Billion JPY -204.737%
JCR Pharmaceuticals Co., Ltd. 5.5 Billion JPY -1374.269%
Daiichi Sankyo Company, Limited 200.73 Billion JPY 59.554%
Otsuka Holdings Co., Ltd. 121.61 Billion JPY 33.242%
Perseus Proteomics Inc. -1.1 Billion JPY 7450.923%